AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research Agenda

Statement on NIH Efforts to Focus Research to End the AIDS Pandemic

NIH logo

Extraordinary progress has been made in HIV/AIDS research over the last 34 years, transforming what was once a terrifying and almost inevitably fatal disease into a treatable disorder. People with HIV/AIDS can now experience an almost normal life expectancy if antiretrovirals are started promptly and continued for life. But the disease remains a significant public…

Appreciating Dr. Jack Whitescarver’s Many Contributions to HIV/AIDS Research

photo whitescarver

At the end of this month, we bid a fond farewell to a colleague who has played a key role in leading Federal research efforts in response to HIV/AIDS since the earliest days of the epidemic. As NIH previously announced, on July 1, 2015, Dr. Jack Whitescarver is retiring and stepping down as NIH’s Associate…

NIH’s Dr. Carl Dieffenbach Shares Highlights as CROI 2015 Begins (Video)

croi2015_w280x100

As the 2015 Conference on Retroviruses and Opportunistic Infections (CROI) got underway in Seattle yesterday, February 23, we spoke with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID). He discussed what we can anticipate hearing more about during this annual scientific meeting that brings…

Scientific Advances in HIV and HCV To Be Examined Next Week at CROI 2015

AIDS.gov

The 2015 Conference on Retroviruses and Opportunistic Infections (CROI)   takes place next week in Seattle, Washington, and AIDS.gov will be there. This annual scientific meeting of the world’s leading researchers working to understand, prevent, and treat HIV/AIDS, hepatitis C (HCV), Ebola, and related infectious diseases provides a vital forum for translating laboratory and clinical research into…

NIH Announces Funding for New Technologies for Viral Hepatitis

nih logo

The National Institutes of Health (NIH) has issued a funding opportunity announcement (FOA) to encourage small businesses to address viral hepatitis research opportunities delineated in the Action Plan for the Prevention, Care, and Treatment of Viral Hepatitis (Action Plan) [PDF 2MB]. The announcement of a Small Business Innovation Research (SBIR) grant entitled New Technologies for Viral…

Scientific Advances on the HIV Care Continuum Presented at CROI

CROI logo

Among the scientific advances highlighted at the 21st Conference of Retroviruses and Opportunistic Infections (CROI)  in Boston, Massachusetts this week were a number of new studies addressing the provision of essential care to persons living with HIV infection, including diagnosis, linkage and retention in care, initiation of antiretroviral treatment (ART), and achievement of durable viral…

Scientific Advances in HIV and Viral Hepatitis To Be Examined This Week at CROI

CROI logo

The 21st Conference on Retroviruses and Opportunistic Infections (CROI)  takes place this week in Boston. This annual scientific meeting of the world’s leading researchers working to understand, prevent, and treat HIV/AIDS and related infectious diseases provides a vital forum for translating laboratory and clinical research into progress against these diseases. More than 4,000 HIV/AIDS research leaders…

NIH Names Leadership, Research Units for Restructured HIV/AIDS Clinical Trials Networks

nih logo

The National Institute of Allergy and Infectious Diseases (NIAID) has selected the principal investigators and clinical trials units (CTUs) that will lead and conduct the research of the five restructured HIV/AIDS clinical trials networks through 2021. The new structure is designed to create a broader, more flexible and more collaborative approach to the networks’ research priorities, which…